A Post-Authorisation Safety Study to Evaluate the Safety of Marstacimab Among Patients with Haemophilia A or B using Real-World Data in Haemophilia Registers

ENCePP Code of conduct

N/A

Data sources

• Data source(s), other:
  The American Thrombosis and Hemostasis Network (ATHN); United Kingdom Haemophilia Centers Doctor’s Organization (UKHCDO)
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No